Results 111 to 120 of about 12,265 (153)

Management of diabetic macular edema: from anti-VEGF to emerging therapies. [PDF]

Front Med (Lausanne)
Ji M, Wei W, Gong H, Zhang G.
europepmc   +1 more source

Impact of Intravitreal Ranibizumab on Retinopathy of Prematurity: A Retrospective Analysis. [PDF]

Cureus
Nitta F, Kunikata H, Watanabe S, Nakazawa T.   +3 more
europepmc   +1 more source

Effects of Subconjunctival Bevacizumab and Ranibizumab on Corneal and Systemic Oxidative Stress Biomarkers in an Alkali Injury Model. [PDF]

Life (Basel)
Yarbağ A, Bardaş Özkan E, Ulaş M, Arslan YK.   +3 more
europepmc   +1 more source

Current and Emerging Pharmacologic Therapies for Diabetic Retinopathy. [PDF]

Pharmacotherapy
Clements JN, Mesawich J, Twisdale C.
europepmc   +1 more source

Comparative evaluation of stability, efficacy, and sterility in five repackaged intravitreal anti-vascular endothelial growth factor medications. [PDF]

Sci Rep
Thunwiriya P, Phetruen T, Chaiwijit P, Tonawannakorn C, Dekham K, Thadtapong N, Chaturongakul S, Charoensawan V, Chanarat S, Pakotiprapha D, Hanutsaha P.   +10 more
europepmc   +1 more source

Assessing the Safety and Efficacy of Agonistic Monoclonal Antibody against Robo4 versus Ranibizumab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Phase I, Open-Label, Multicenter Study. [PDF]

Ophthalmol Sci
Afridi R, Senaldi G, Hwang JJ, Nguyen N, Inoue T, Berger B, Patel S, Fazal ZZ, Nguyen QD, Sepah Y.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Ranibizumab

Drugs, 2012
Antona J Wagstaff, Wagstaff Antona J
exaly   +4 more sources

Ranibizumab

Drugs, 2007
Ranibizumab is the antigen-binding fragment of a recombinant, humanised monoclonal antibody, which binds with high affinity to, and inhibits the activity of, all active forms of vascular endothelial growth factor A, an important mediator in the development of choroidal neovascularisation.
Stephanie K A, Blick, Gillian M, Keating, Antona J, Wagstaff   +2 more
openaire   +3 more sources